888327-36-4Relevant articles and documents
Preparation method of 2-bromo-5-(trifluoromethoxy)pyridine
-
Paragraph 0061; 0073-0076; 0088-0090, (2022/01/12)
The invention discloses a preparation method of 2-bromine-5-(trifluoromethoxy)pyridine, which comprises the following steps: reacting 2-bromo-5-hydroxypyridine (compound 1) with ethyl difluorobromoacetate (compound 1A) in the presence of organic alkali to generate a compound 2; carrying out ester group hydrolysis reaction on the compound 2 in the presence of an alkaline reagent to generate a compound 3; carrying out acylating chlorination on carboxyl of the compound 3 and oxalyl chloride under the catalysis of N,N-dimethylformamide, concentrating reaction liquid, and dropwise adding the concentrated reaction liquid and 2,2'-azodiisobutyronitrile (AIBN) into a bromotrichloromethane solution of 2-mercaptopyridine nitrogen oxide sodium salt (compound 3A) to obtain a compound 4; and dropwise adding a silver tetrafluoroborate solution into the solution of the compound 4, and conducting reacting to generate the final product 2-bromo-5-(trifluoromethoxy)pyridine. The method has the advantages of environment-friendly and easily available raw materials, mild conditions, easiness in operation, suitability for kilogram-level production and the like.
METHOD FOR THE PREPARATION OF FUNCTIONALIZED TRIHALOMETHOXY SUBSTITUTED PYRIDINES
-
Page/Page column 38-39, (2010/04/28)
The present invention pertains to a process for the preparation of functionalized trihalomethoxypyridines of formula (I) comprising reacting hydroxypyridines with thiophosgene in the presence of a base; reacting the obtained chlorothionoformiates with elemental chlorine and finally converting trichloromethoxy pyridines to trihalomethoxy pyridines using a fluoride source.
SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR
-
Page/Page column 90, (2015/10/07)
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.